277 related articles for article (PubMed ID: 22863328)
1. Spray-applied cell therapy with human allogeneic fibroblasts and keratinocytes for the treatment of chronic venous leg ulcers: a phase 2, multicentre, double-blind, randomised, placebo-controlled trial.
Kirsner RS; Marston WA; Snyder RJ; Lee TD; Cargill DI; Slade HB
Lancet; 2012 Sep; 380(9846):977-85. PubMed ID: 22863328
[TBL] [Abstract][Full Text] [Related]
2. The influence of patient and wound variables on healing of venous leg ulcers in a randomized controlled trial of growth-arrested allogeneic keratinocytes and fibroblasts.
Lantis JC; Marston WA; Farber A; Kirsner RS; Zhang Y; Lee TD; Cargill DI; Slade HB
J Vasc Surg; 2013 Aug; 58(2):433-9. PubMed ID: 23588112
[TBL] [Abstract][Full Text] [Related]
3. Durability of healing from spray-applied cell therapy with human allogeneic fibroblasts and keratinocytes for the treatment of chronic venous leg ulcers: a 6-month follow-up.
Kirsner RS; Marston WA; Snyder RJ; Lee TD; Cargill DI; Zhang Y; Dickerson JE; Slade HB
Wound Repair Regen; 2013; 21(5):682-7. PubMed ID: 23927847
[TBL] [Abstract][Full Text] [Related]
4. Wound stimulation by growth-arrested human keratinocytes and fibroblasts: HP802-247, a new-generation allogeneic tissue engineering product.
Goedkoop R; Juliet R; You PH; Daroczy J; de Roos KP; Lijnen R; Rolland E; Hunziker T
Dermatology; 2010; 220(2):114-20. PubMed ID: 20110630
[TBL] [Abstract][Full Text] [Related]
5. Clinical and cost-effectiveness of compression hosiery versus compression bandages in treatment of venous leg ulcers (Venous leg Ulcer Study IV, VenUS IV): a randomised controlled trial.
Ashby RL; Gabe R; Ali S; Adderley U; Bland JM; Cullum NA; Dumville JC; Iglesias CP; Kang'ombe AR; Soares MO; Stubbs NC; Torgerson DJ
Lancet; 2014 Mar; 383(9920):871-9. PubMed ID: 24315520
[TBL] [Abstract][Full Text] [Related]
6. A prospective randomised trial of four-layer versus short stretch compression bandages for the treatment of venous leg ulcers.
Scriven JM; Taylor LE; Wood AJ; Bell PR; Naylor AR; London NJ
Ann R Coll Surg Engl; 1998 May; 80(3):215-20. PubMed ID: 9682649
[TBL] [Abstract][Full Text] [Related]
7. A pilot multi-centre prospective randomised controlled trial of RECELL for the treatment of venous leg ulcers.
Hayes PD; Harding KG; Johnson SM; McCollum C; Téot L; Mercer K; Russell D
Int Wound J; 2020 Jun; 17(3):742-752. PubMed ID: 32103603
[TBL] [Abstract][Full Text] [Related]
8. Multicentre, randomised controlled trial of four-layer bandaging versus short-stretch bandaging in the treatment of venous leg ulcers.
Partsch H; Damstra RJ; Tazelaar DJ; Schuller-Petrovic S; Velders AJ; de Rooij MJ; Sang RR; Quinlan D
Vasa; 2001 May; 30(2):108-13. PubMed ID: 11417280
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of the freeze-dried cultured human keratinocyte lysate, LyphoDerm 0.9%, in the treatment of hard-to-heal venous leg ulcers.
Harding KG; Krieg T; Eming SA; Flour ML; Jawien A; Cencora A; Kaszuba A; Noszcyk W; Willems P; De Deene A; Joos E; De Waele P; Delaey B
Wound Repair Regen; 2005; 13(2):138-47. PubMed ID: 15828938
[TBL] [Abstract][Full Text] [Related]
10. Comparison of low-strength compression stockings with bandages for the treatment of recalcitrant venous ulcers.
Brizzio E; Amsler F; Lun B; Blättler W
J Vasc Surg; 2010 Feb; 51(2):410-6. PubMed ID: 19879713
[TBL] [Abstract][Full Text] [Related]
11. Low dose aspirin as adjuvant treatment for venous leg ulceration: pragmatic, randomised, double blind, placebo controlled trial (Aspirin4VLU).
Jull A; Wadham A; Bullen C; Parag V; Kerse N; Waters J
BMJ; 2017 Nov; 359():j5157. PubMed ID: 29175902
[No Abstract] [Full Text] [Related]
12. Treatment of recalcitrant venous leg ulcers with autologous keratinocytes in fibrin sealant: a multinational randomized controlled clinical trial.
Vanscheidt W; Ukat A; Horak V; Brüning H; Hunyadi J; Pavlicek R; Emter M; Hartmann A; Bende J; Zwingers T; Ermuth T; Eberhardt R
Wound Repair Regen; 2007; 15(3):308-15. PubMed ID: 17537117
[TBL] [Abstract][Full Text] [Related]
13. Risk factors related to the failure of venous leg ulcers to heal with compression treatment.
Milic DJ; Zivic SS; Bogdanovic DC; Karanovic ND; Golubovic ZV
J Vasc Surg; 2009 May; 49(5):1242-7. PubMed ID: 19233601
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of an electroceutical device in treating non-healing venous leg ulcers: results of an RCT.
Guest JF; Singh H; Rana K; Vowden P
J Wound Care; 2018 Apr; 27(4):230-243. PubMed ID: 29637824
[TBL] [Abstract][Full Text] [Related]
15. Maggots as a wound debridement agent for chronic venous leg ulcers under graduated compression bandages: A randomised controlled trial.
Davies CE; Woolfrey G; Hogg N; Dyer J; Cooper A; Waldron J; Bulbulia R; Whyman MR; Poskitt KR
Phlebology; 2015 Dec; 30(10):693-9. PubMed ID: 25300315
[TBL] [Abstract][Full Text] [Related]
16. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Human Skin Equivalent Investigators Group.
Falanga V; Margolis D; Alvarez O; Auletta M; Maggiacomo F; Altman M; Jensen J; Sabolinski M; Hardin-Young J
Arch Dermatol; 1998 Mar; 134(3):293-300. PubMed ID: 9521027
[TBL] [Abstract][Full Text] [Related]
17. Use of weekly, low dose, high frequency ultrasound for hard to heal venous leg ulcers: the VenUS III randomised controlled trial.
Watson JM; Kang'ombe AR; Soares MO; Chuang LH; Worthy G; Bland JM; Iglesias C; Cullum N; Torgerson D; Nelson EA;
BMJ; 2011 Mar; 342():d1092. PubMed ID: 21385806
[TBL] [Abstract][Full Text] [Related]
18. Effect of amelogenin extracellular matrix protein and compression on hard-to-heal venous leg ulcers.
Vowden P; Romanelli M; Price P
J Wound Care; 2007 May; 16(5):189-95. PubMed ID: 17552400
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of an ulcer compression stocking for therapy of chronic venous ulcer compared with a below-knee compression bandage: results from a prospective, randomized, multicentre trial.
Jünger M; Wollina U; Kohnen R; Rabe E
Curr Med Res Opin; 2004 Oct; 20(10):1613-23. PubMed ID: 15462694
[TBL] [Abstract][Full Text] [Related]
20. Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial.
Paz-Ares L; de Marinis F; Dediu M; Thomas M; Pujol JL; Bidoli P; Molinier O; Sahoo TP; Laack E; Reck M; Corral J; Melemed S; John W; Chouaki N; Zimmermann AH; Visseren-Grul C; Gridelli C
Lancet Oncol; 2012 Mar; 13(3):247-55. PubMed ID: 22341744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
